DSM is pleased to report that nature-identical zeaxanthin receives a positive opinion on safety from EFSA
Together with lutein, zeaxanthin is one of the main components of the macular pigment. It is deposited into the human macula, the small, highly sensitive area of the retina responsible for central vision where it works as a blue light filter and as an antioxidant.
Zeaxanthin, and more specifically OPTISHARP Zeaxanthin, has been the subject of numerous publications. Several scientific peer reviewed studies demonstrate the antioxidant role of zeaxanthin in the retina and the lens, and it is acknowledged by eye health professionals as playing a positive role in eye health. OPTISHARP is being used at 2mg dose/day, in combination with DSM’s FloraGlo® Lutein2, in the on-going study AREDS 2 (Age Related Eye Disease Study) sponsored by the National Eye Institute of the National Institutes of Health in the United States.
1 OPTISHARP is a registered trademark of DSM
2 FloraGLO is a registered trademark of Kemin Industries, Inc.